@article{f1c94223e94f4a198256b01dd03e641c,
title = "Alternative and complementary therapies: Glucosamine/Chondroitin: Still waiting for an answer",
abstract = "Results of the four-year study entitled the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) provided partial answers to those seeking relief from arthritis pain. Scientists will continue studying the efficacy of these substances as pain remedy and cartilage rejuvenator.",
author = "Dell, {Esther Y.} and Shultz, {Suzanne M.}",
note = "Funding Information: In November 2000, a four-year study entitled the Glucosamine/ chondroitin Arthritis Intervention Trial (GAIT) was begun. GAIT was jointly funded by the National Center for Complementary Medicine (NCCAM) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and was led by Daniel O. Clegg, MD, a rheumatologist from the University of Utah School of Medicine in Salt Lake City. It was conducted in 16 centers throughout the United States. Dr. Clegg noted in a press release in February 2006 that the goal “was to assess whether glucosamine and chondroitin sulfate, which we saw our osteoarthritis patients using, provided pain relief.”3 NIH Director Elias",
year = "2006",
doi = "10.1300/J381v10n04_09",
language = "English (US)",
volume = "10",
pages = "95--101",
journal = "Journal of Consumer Health on the Internet",
issn = "1539-8285",
publisher = "Taylor and Francis Ltd.",
number = "4",
}